Clobetasone

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LT69WY1J6D. European Medicines Agency schedules Clobetasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06679MIG. Clobetasone generally arises in the molecular formula C22H26CLFO4. The term CLOBETASONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, no. 10 1972, list 12.) CLOBETASONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clobetasone under HS 29372200 and SITC 54153. As of Q4 2014, CLOBETASONE remains the US FDA Preferred Term for this commodity. Clobetasone bears US NLM identifiers UMLS ID C0360518 and NCI Concept Code C77408. SMILES: CLCC(=O)C1(O)C2(C(C3C(F)(C4(C(=CC(=O)C=C4)CC3)C)C(=O)C2)CC1C)C.